Cx59

Gefitinib-based PROTAC 3 : Aptamer-PROTAC Conjugates (APCs) for Tumor-specific Targeting in Breast Cancer

SGX-523 : Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways

Tepotinib : Tepotinib: First Approval

Trimetazidine : Effect of age and renal impairment on the pharmacokinetics and safety of trimetazidine: An open-label multiple-dose study

Menin-MLL Inhibitor : Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin–mixed lineage leukaemia interface

Asunaprevir : Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation

GCN2iB: D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation

LY3023414 : Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

Telaglenastat : Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models